Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in ALS
NCT00690118Phase 2Terminated
- Sponsor
- Ulm University
- Start
- May 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in amyotrophic lateral sclerosis (ALS), sponsored by Ulm University. Started May 2008; status: terminated.
02
Drugs
pioglitazone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00690118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690118.